Testing effectiveness (Phase 2)Looking for participantsNCT05582122
What this trial is testing
SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers
Who this might be right for
Oropharynx Squamous Cell Carcinoma
UNICANCER 420